Chief Executive Officer
CurrentEdgewood is a clinical-stage biotech advancing BTX-A51, a promising multi-kinase inhibitor, in AML and targeted solid tumor populations.
Please complete the CAPTCHA to continue
@formatherapeutics.com
✓
6 phones found area 212, 617, 215, and 925
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
David Cook is listed as Biotech CEO at Edgewood Oncology, based in Boston, Massachusetts, United States. AeroLeads shows a work email signal at formatherapeutics.com, phone signal with area code 212, 617, 215, 925, and a matched LinkedIn profile for David Cook.
David Cook previously worked as Chief Executive Officer at Edgewood Oncology and SVP Research and Chief Scientific Officer at Forma Therapeutics, Inc.. David Cook holds A.B., American Studies from Harvard University.
This section adds company-level context without repeating David Cook's masked contact details.
AeroLeads found 1 current-domain work email signal for David Cook. Compare company email patterns before reaching out.
Accomplished senior executive and developer of biotechnology products. Experienced with microbiome therapeutics, vaccines, small molecules, and biologics. Involved in all aspects of product development including discovery research, clinical trials, regulatory affairs, manufacturing, business development, intellectual property and corporate operations. Directly responsible for obtaining the EU marketing authorization for four novel medical products.Specialties: Microbiome, Infectious Disease, Vaccines and Immunotherapy, Inflammation and Immunology, Immuno-oncology
Listed skills include Biotechnology, Clinical Trials, Infectious Diseases, Oncology, and 14 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Edgewood is a clinical-stage biotech advancing BTX-A51, a promising multi-kinase inhibitor, in AML and targeted solid tumor populations.
Watertown, Massachusetts, US
Forma focused on rare hematology and targeted oncology with a field-leading PKR activator for sickle cell disease. Acquired by Novo Nordisk in Oct 2022.
Waltham, Massachusetts, US
X-Biotix is a biotech company specializing in the development of novel small molecule antibiotic scaffolds for multi-drug resistant (MDR) gram-negative pathogens to address the urgent and growing global threat of antibiotic resistance.
Cambridge, Massachusetts, US
Over the past century, antibiotics, changes in nutrition, and other environmental factors have dramatically altered the shape of the human microbiome. These microbial ecologies residing in and on the human body are now understood to be vital to our health. Seres is pioneering a new approach to fundamentally restore and maintain healthy microbiomes. In it's.
New York, NY, US
The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. Founded in 1996 and operational in 25 countries, IAVI and its network of collaborators research and develop vaccine candidates. As chief.
Seattle, Washington, US
Consultant working to develop strategy to bring biotech companies into global health field
US
Anza Therapeutics’ mission is to develop therapeutic and prophylactic vaccines based on its proprietary vaccine platforms. Company is a biotech start-up funded by venture firms Versant Ventures, Kleiner Perkins and Sofinnova Ventures.
US
Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety.
Development-stage, venture-funded company commercializing proprietary cell selection products for engineering of hematopoietic stem cells. Acquired in 2001 by BioTransplant, Inc.
Quick answers generated from the profile data available on this page.
David Cook works for Edgewood Oncology.
David Cook is listed as Biotech CEO at Edgewood Oncology.
AeroLeads has found 1 work email signal at @formatherapeutics.com for David Cook at Edgewood Oncology.
AeroLeads has found 6 phone signal(s) with area code 212, 617, 215, 925 for David Cook at Edgewood Oncology.
David Cook is based in Boston, Massachusetts, United States while working with Edgewood Oncology.
David Cook has worked for Edgewood Oncology, Forma Therapeutics, Inc., X-Biotix Therapeutics, Inc., David N. Cook Consulting, and Seres Therapeutics.
You can use AeroLeads to view verified contact signals for David Cook at Edgewood Oncology, including work email, phone, and LinkedIn data when available.
David Cook holds A.B., American Studies from Harvard University.
David Cook is listed with skills including Biotechnology, Clinical Trials, Infectious Diseases, Oncology, R&D, Regulatory Affairs, Pharmaceutical Industry, and Life Sciences.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts